Clinical Trial

ED50 of Remimazolam for Anesthesia Induction in Frail Elderly Patients

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to determine the median effective dose (ED50) of remimazolam for loss of consciousness (LOC) in elderly and frail elderly patients using the Dixon up-and-down method, while utilizing a novel Respiratory Volume Monitor (RVM) to detect subclinical respiratory depression.
Trial Details
NCT Number NCT07467603
Lead Sponsor The First Hospital of Hebei Medical University
Conditions Frailty, Anesthesia Induction
Enrollment 58 participants
Start Date 2025-02-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-12